These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11778975)

  • 41. Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report.
    Zerna C; Guenther M; Folprecht G; Puetz V
    J Chemother; 2017 Feb; 29(1):49-53. PubMed ID: 25579322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vinorelbine: an overview.
    Johnson SA; Harper P; Hortobagyi GN; Pouillart P
    Cancer Treat Rev; 1996 Mar; 22(2):127-42. PubMed ID: 8665565
    [No Abstract]   [Full Text] [Related]  

  • 43. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
    Jones SF; Burris HA
    Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN
    Acta Oncol; 2007; 46(3):361-6. PubMed ID: 17450472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
    Wozniak AJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case report of vinorelbine monotherapy-related acute bronchospasm and non-ST elevation acute coronary syndrome.
    Goli AK; Osman MN; Koduri M; Byrd RP; Roy TM
    Tenn Med; 2011 Jan; 104(1):47-8. PubMed ID: 21314064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
    Miyata J; Sano T; Bando H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
    Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
    Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vinorelbine (Navelbine): a third-generation vinca alkaloid.
    Budman DR
    Cancer Invest; 1997; 15(5):475-90. PubMed ID: 9316630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.
    Miyata J; Sano T; Bando H
    Med Oncol; 2002; 19(1):11-4. PubMed ID: 12025886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.
    Martin M; Casado A; Perez Segura P; Garcia Carbonero I; Diaz-Rubio E
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):28-30. PubMed ID: 9516600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S; Matsubara N; Sakai T; Aso N
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract]   [Full Text] [Related]  

  • 55. [Adverse (cardio-)vascular effects of vinorelbine in non-small-cell bronchial carcinoma].
    Kirschner J; Kolb M; Müller J; Jacobi I
    Pneumologie; 2000 Feb; 54(2):54-7. PubMed ID: 10731757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of non-small-cell lung cancer in an older adult with complications responding to vinorelbine single agent].
    Nagasawa M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1673-4. PubMed ID: 21996964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Respiratory complications of the vinorelbine-mitomycin combination].
    Rouzaud P; Estivals M; Pujazon MC; Carles P; Lauque D
    Rev Mal Respir; 1999 Feb; 16(1):81-4. PubMed ID: 10091264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single agents in the second-line treatment of non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):10-4. PubMed ID: 9704670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Jun; 271(23):1818. PubMed ID: 7910857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.